Dr Eleni Hagi-Pavli
Senior Lecturer
Dental Institute, Centre for Oral Immunobiology and Regenerative
Faculty of Medicine and Dentistry, Queen Mary University of London
Faculty of Medicine and Dentistry, Queen Mary University of London
Publications
2023
Koidou VP, Hagi‐Pavli E, Nibali L and Donos N (2023). Elucidating the molecular healing of intrabony defects following non‐surgical periodontal therapy: A pilot study. Wiley Journal of Periodontal Research vol. 59, (1) 53-62. 10.1111/jre.13207
Alhallak K, Hagi-Pavli E and Nankali A (2023). A review on clinical use of CAD/CAM and 3D printed dentures. Springer Nature British Dental Journal 1-5. 10.1038/s41415-022-5401-5
2022
Karen-Ng LP, Ahmad US, Gomes L, Hunter KD, Wan H, Hagi-Pavli E and Parkinson EK (2022). Extracellular Prostaglandins E1 and E2 and Inflammatory Cytokines Are Regulated by the Senescence Program in Potentially Premalignant Oral Keratinocytes. Mdpi Cancers vol. 14, (11) 10.3390/cancers14112636
Nibali L, Stephen A, Hagi-Pavli E, Allaker R, Pino AD, Terranova V, Pisano M, Marca SD, Ferrara V, Scicali R, Giordano M, Purrello F, Donos N and Malatino L (2022). Analysis of gingival crevicular fluid biomarkers in patients with metabolic syndrome. Elsevier Journal of Dentistry vol. 118, 10.1016/j.jdent.2022.104065
2021
Novak T, Hamedi M, Bergmeier LA, Fortune F and Hagi-Pavli E (2021). Saliva and Serum Cytokine Profiles During Oral Ulceration in Behçet’s Disease., Editors: Czerkinsky C. Frontier Frontiers in Immunology vol. 12, (22) 724900-724920. 10.3389/fimmu.2021.724900
Koidou VP, Hagi‐Pavli E, Cross S, Nibali L and Donos N (2021). Molecular profiling of intrabony defects' gingival crevicular fluid. Wiley Journal of Periodontal Research vol. 57, (1) 152-161. 10.1111/jre.12948
2020
Koidou VP, Cavalli N, Hagi-Pavli E, Nibali L and Donos N (2020). Expression of inflammatory biomarkers and growth factors in gingival crevicular fluid at different healing intervals following non-surgical periodontal treatment: A systematic review. Wiley Journal of Periodontal Research 10.1111/jre.12795
Novak T, Fortune F, Bergmeier L, Khan I and Hagi-Pavli E (2020). Neutrophil elastase and endogenous inhibitors in Behçet’s disease saliva. Wiley Clinical and Experimental Immunology 10.1111/cei.13483
2015
Seoudi N, Bergmeier LA, Hagi-Pavli E, Bibby D and Fortune F (2015). The seroprevalence and salivary shedding of herpesviruses in Behçet's syndrome and recurrent aphthous stomatitis. Taylor & Francis Journal of Oral Microbiology vol. 7, (1) 10.3402/jom.v7.27156
2014
Hagi-Pavli E, Williams DM, Rowland JL, Thornhill M and Cruchley AT (2014). Characterizing the immunological effects of oral healthcare ingredients using an in vitro reconstructed human epithelial model. Food Chem Toxicol vol. 74, 139-148. 10.1016/j.fct.2014.09.007
Hamedi M, Bergmeier LA, Hagi-Pavli E, VARTOUKIAN SR and Fortune F (2014). Differential expression of Suppressor of Cytokine Signalling proteins in Behçet’s Disease. Wiley Online Scandinavian Journal of Immunology vol. 80, (5) 369-376. 10.1111/sji.12211
Seoudi N, Bergmeier LA, Hagi-Pavli E, Bibby D, Curtis MA and Fortune F (2014). The role of TLR2 and 4 in Behçet's disease pathogenesis. Innate Immun vol. 20, (4) 412-422. 10.1177/1753425913498042
Bergmeier LA, Hamedi M, Hagi-Pavli E, Seoudi N, Senusi A, Ijaz H and Fortune F (2014). HSP27 as a diagnostic marker in the saliva of Behcet's disease.
2013
WHILEY RA, Sheikh NP, Mushtaq N, Hagi-Pavli E, Personne Y, Javaid D and Waite RD (2013). Differential Potentiation of Virulence of the Pseudomonas aeruginosa Cystic Fibrosis. Oxford Journals Epidemics: The Journal of Infectious Diseases vol. 209, (5) 769-780. 10.1093/infdis/jit568
Adegun OK, Tomlins PH, Hagi-Pavli E, Bader DL and Fortune F (2013). Quantitative optical coherence tomography of fluid-filled oral mucosal lesions. Lasers Med Sci vol. 28, (5) 1249-1255. 10.1007/s10103-012-1208-y
2012
Adegun OK, Tomlins PH, Hagi-Pavli E, McKenzie G, Piper K, Bader DL and Fortune F (2012). Quantitative analysis of optical coherence tomography and histopathology images of normal and dysplastic oral mucosal tissues. Lasers Med Sci vol. 27, (4) 795-804. 10.1007/s10103-011-0975-1
Whiley RA, Cruchley AT, Gore C and Hagi-Pavli E (2012). Candida albicans strain-dependent modulation of pro-inflammatory cytokine release by in vitro oral and vaginal mucosal models. Cytokine vol. 57, (1) 89-97. 10.1016/j.cyto.2011.10.017
2011
Macey M, Hagi-Pavli E, Stewart J, Wallace GR, Stanford M, Shirlaw P and Fortune F (2011). Age, gender and disease-related platelet and neutrophil activation ex vivo in whole blood samples from patients with Behçet's disease. Rheumatology (Oxford) vol. 50, (10) 1849-1859. 10.1093/rheumatology/ker177
2010
Tomlins PH, Adegun O, Hagi-Pavli E, Piper K, Bader D and Fortune F (2010). Scattering attenuation microscopy of oral epithelial dysplasia. Spie Journal of Biomedical Optics vol. 15, (6) 10.1117/1.3505019
Bergmeier LA, Adegun O, Seoudi N, Hamedi M, Hagi-Pavli E and Fortune F (2010). INDUCIBLE HUMAN HEAT SHOCK PROTEIN (HSP70) IS ELEVATED IN THE SALIVA OF BEHCET'S PATIENTS. Clin Exp Rheumatol vol. 28, (4) S123-S123.
Seoudi N, Hagi-Pavli E, Bergmeier L, Stewart J, Curtis M and Fortune F (2010). THE ORAL HEALTH AND MICROBIOTA OF UK BEHCET'S DISEASE PATIENTS. Clin Exp Rheumatol vol. 28, (4) S124-S124.
Hagi-Pavli E, Macey M, Stewart J, Wallace G, Stanford M, Shirlaw P and Fortune F (2010). AGE, GENDER AND DISEASE RELATED PLATELET AND NEUTROPHIL ACTIVATION IN BEHCET'S. Clin Exp Rheumatol vol. 28, (4) S128-S128. 10.1093/rheumatology/ker177
Hagi-Pavli E, Bergmeier L, Khan I, Seoudi N and Fortune F (2010). SECRETORY LEUKOCYTE PROTEASE INHIBITOR (SLPI) IN BEHCET'S PATIENTS SALIVA. Clin Exp Rheumatol vol. 28, (4) S128-S128.
Hagi-Pavli E, Novak T, Bergmeier L, Seoudi N, Moeinian M and Fortune F (2010). PLASMA AND SALIVA CYTOKINE PROFILES IN BEHCET'S DISEASE: DO CYTOKINE LEVELS IN PLASMA CORRELATE WITH LEVELS IN SALIVA? Clin Exp Rheumatol vol. 28, (4) S129-S129.
2009
Mumcu G, Niazi S, Stewart J, Hagi-Pavli E, Gokani B, Seoudi N, Ergun T, Yavuz S, Stanford M, Fortune F and Direskeneli H (2009). Oral health and related quality of life status in patients from UK and Turkey: a comparative study in Behcet's disease. J Oral Pathol Med vol. 38, (5) 406-409. 10.1111/j.1600-0714.2009.00752.x
2008
Teh MT, Tilakaratne WM, Chaplin T, Young BD, Ariyawardana A, Pitiyage G, Lalli A, Stewart JE, Hagi-Pavli E, Cruchley A, Waseem A and Fortune F (2008). Fingerprinting genomic instability in oral submucous fibrosis. J Oral Pathol Med vol. 37, (7) 430-436. 10.1111/j.1600-0714.2008.00643.x
Stewart JE, Mumcu G, Haque A, Hagi-Pavli E, Freysdot J, Direskeneli H, Shirlaw P, Wallace G, Stanford MR and Fortune F (2008). DIFFERENTIAL CYTOKINE EXPRESSION BY PBMC'S OF BEHCET'S PATIENTS: INFLUENCE OF SERUM AND SALIVA. Clin Exp Rheumatol vol. 26, (4) S9-S9.
Tilakaratne WM, Iqbal Z, Teh MT, Ariyawardana A, Pitiyage G, Cruchley A, Stewart JE, Hagi-Pavli E, Lalli A, Waseem A, Parkinson EK and Fortune F (2008). Upregulation of HIF-1 alpha in malignant transformation of oral submucous fibrosis. J Oral Pathol Med vol. 37, (6) 372-377. 10.1111/j.1600-0714.2007.00625.x
Mumcu G, Stewart J, Hagi-Pavli E, Gokani B, Seoudi N, Ergun T, Yavuz S, Stanford MR, Direskeneli H and Fortune F (2008). ORAL HEALTH AND QUALITY OF LIFE STATUS IN PATIENTS FROM UK AND TURKEY: A COMPARATIVE STUDY IN BEHCET'S DISEASE. Clin Exp Rheumatol vol. 26, (4) S5-S6. 10.1111/j.1600-0714.2009.00752.x
Hagi-Pavli E, Plequezuelos O, Seoudi N, Stewart JE, Shirlaw P, Wallace G, Stanford MR and Fortune F (2008). EXPRESSION OF EPIDERMAL GROWTH FACTOR RECEPTOR AND ITS LIGANDS IN THE ORAL CAVITY OF BEHCET'S DISEASE PATIENTS. Clin Exp Rheumatol vol. 26, (4) S9-S10.
Lalli A, Tilakaratne WM, Ariyawardana A, Fitchett C, Leigh IM, Hagi-Pavli E, Cruchley AT, Parkinson EK, Teh MT, Fortune F and Waseem A (2008). An altered keratinocyte phenotype in oral submucous fibrosis: correlation of keratin K17 expression with disease severity. J Oral Pathol Med vol. 37, (4) 211-220. 10.1111/j.1600-0714.2007.00609.x
2007
Tilakaratne W, Iqbal Z, Teh MT, Ariyawardana A, Pitiyage G, Cruchley A, Hagi-Pavli E, Lalli A, Waseem A, Parkinson K and Fortune F (2007). P245 Up regulation of HIF-1a in the progression and malignant transformation of oral submucous fibrosis. Elsevier Oral Oncology Supplement vol. 2, (1) 204-205. 10.1016/s1744-7895(07)70522-9
2005
Tosanguan J, Hagi-Pavli E, Kapas S and Cruchley AT (2005). The role NF-kappa Bin mercury-induced IL-8 production by oral keratinocytes. Immunology vol. 116, 28-29.
Hagi-Pavli E, Farthing PM, Henshaw FN and Kapas S (2005). Presentation of ICAM-1 protein at the cell surface of oral keratinocytes in the presence of adrenomedullin and corticotrophin. Cell Physiol Biochem vol. 15, (1-4) 167-174. 10.1159/000083649
2004
Pleguezuelos O, Hagi-Pavli E, Crowther G and Kapas S (2004). Adrenomedullin signals through NF-kappaB in epithelial cells. Febs Lett vol. 577, (1-2) 249-254. 10.1016/j.febslet.2004.10.019
Kapas S, Pahal K, Cruchley AT, Hagi-Pavli E and Hinson JP (2004). Expression of adrenomedullin and its receptors in human salivary tissue. J Dent Res vol. 83, (4) 333-337. 10.1177/154405910408300412
Hagi-Pavli E, Farthing PM and Kapas S (2004). Stimulation of adhesion molecule expression in human endothelial cells (HUVEC) by adrenomedullin and corticotrophin. Am J Physiol Cell Physiol vol. 286, (2) C239-C246. 10.1152/ajpcell.00036.2003
2003
Lundqvist CK, Hagi-Pavli E, Kapas S, Williams DM, Thornhill MH and Cruchley A (2003). HgCl2 induction of oral keratimacyte IL-8 production is mediated by the MAP kinase pathway. J Dent Res vol. 82, B95-B95.
2001
Kapas S, Bansal A, Bhargava V, Maher R, Malli D, Hagi-Pavli E and Allaker RP (2001). Adrenomedullin expression in pathogen-challenged oral epithelial cells. Peptides vol. 22, (9) 1485-1489. 10.1016/S0196-9781(01\)00470-3
CRUCHLEY AT, Leigh IM, Navsaria H, Williams DM, Hagi-Pavli EP, Wertz PW, Selvaratnam L and Squier CA (2001). Permeability barrier properties of oral keratinocyte cultures: a model of intact human oral mucosa. Oral Diseases vol. 7, (4) 252-258. 10.1034/j.1601-0825.2001.70409.x
2000
Ellone MM, Cruchley AT, Hagi-Pavli E, Patel M, Braden M and Williams DM (2000). PERMEABILITY OF ORAL MUCOSAL TISSUES TO DEXAMETHASONE. Portland Press Biochemical Society Transactions vol. 28, (5) a201-a201. 10.1042/bst028a201a
1999
Hagi‐Pavli EP, Simms CS, Ostler EL, Brocklehurst K and Gallacher G (1999). ChemInform Abstract: Synthesis of a Transition State Analogue for the Hydrolysis of Cocaine: Assistance to Phosphonylation of a 3β‐Hydroxytropane by a Neighboring Amide Group. Wiley Cheminform vol. 30, (43) no-no. 10.1002/chin.199943209
Hagi-Pavli EP, Simms CS, Ostler EL, Brocklehurst K and Gallacher G (1999). Synthesis of a transition state analogue for the hydrolysis of cocaine: Assistance to phosphonylation of a 3β-hydroxytropane by a neighbouring amide group. Elsevier Bioorganic & Medicinal Chemistry Letters vol. 9, (13) 1881-1884. 10.1016/s0960-894x(99)00293-0
1998
Kapas S, Hagi‐Pavli E, Brown DW, Chhajlani V and Farthing PM (1998). Direct effects of corticotrophin on oral keratinocyte cell proliferation. Wiley The Febs Journal vol. 256, (1) 75-79. 10.1046/j.1432-1327.1998.2560075.x
Taichman NS, Cruchley AT, Fletcher LM, Hagi-Pavli EP, Paleolog EM, Abrams WR, Booth V, Edwards RM and Malamud D (1998). Vascular endothelial growth factor in normal human salivary glands and saliva: a possible role in the maintenance of mucosal homeostasis. Laboratory Investigation vol. 78, (7) 869-875.
1997
Kapas S, Brown DW, Farthing PM and Hagi-Pavli E (1997). Adrenomedullin has mitogenic effects on human oral keratinocytes: involvement of cyclic AMP. Wiley Febs Letters vol. 418, (3) 287-290. 10.1016/s0014-5793(97)01384-7
Hinson JP, Hagi-Pavli E, Thomson LM and Kapas S (1997). PROADRENOMEDULLIN N-TERMINAL 20-PEPTIDE (PAMP) RECEPTORS AND SIGNAL TRANSDUCTION IN THE RAT ADRENAL GLAND. Elsevier Life Sciences vol. 62, (5) 439-443. 10.1016/s0024-3205(97)01137-5
Kapas S, Thomson L, Hagi-Pavli E and Hinson JP (1997). Pro-adrenomedullfn 20 peptide (pamp) binds to specific-receptors in the rat adrenal gland. Faseb Journal vol. 11, (9)
RESMINI M, VIGNA R, SIMMS C, BARBER NJ, HAGI-PAVLI EP, WATTS AB, VERMA C, GALLACHER G and BROCKLEHURST K (1997). Characterization of the hydrolytic activity of a polyclonal catalytic antibody preparation by pH-dependence and chemical modification studies: evidence for the involvement of Tyr and Arg side chains as hydrogen-bond donors. Portland Press Biochemical Journal vol. 326, (1) 279-287. 10.1042/bj3260279